| 发明名称 |
URINARY TRIAOSYLCERAMIDE (GB3) AS A MARKER OF CARDIAC DISEASE |
| 摘要 |
<p>The present invention describes a method for determination of urinary globotriaosylceramide (Gb3) levels in non-Fabry disease cardiac patients. Determination of Gb3 levels provides a screening method for determining cardiac risk and may offer an alternative therapeutic option for cardiac disease management or cardiac disease risk mitigation by lowering Gb3 levels by the use of pharmacological chaperones or other agents.</p> |
| 申请公布号 |
EP2502068(A2) |
申请公布日期 |
2012.09.26 |
| 申请号 |
EP20100832140 |
申请日期 |
2010.11.17 |
| 申请人 |
BAYLOR RESEARCH INSTITUTE |
发明人 |
SCHIFFMANN, RAPHAEL;MOCHEL, FANNY;SWEETMAN, LAWRENCE;FORNI, SABRINA |
| 分类号 |
G01N33/493;A61B10/00;A61K31/445;A61K38/47;G01N30/72 |
主分类号 |
G01N33/493 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
